CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
GLIORESOLVE focuses on developing precision medicine therapies for the aggressive brain tumor, IDHwt glioblastoma. The project aims to enhance immunotherapy options, create advanced pre-clinical models, and identify specific therapeutic targets based on tumor microenvironments, ultimately leading to a Phase 2 clinical…
Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brain tumour.
It has a universally fatal prognosis with 85% of patients dying within two years.
Effective precision medicine therapies are thus urgently required.
This can only be achieved by focused multi-sectoral collaborations in innovative research disciplines.
Overall, GLIORESOLVE will exploit the intractability of GBM to address European applied biomedical research training needs and wi…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Belgium, Leuven
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Netherlands, Rotterdam
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
VLAAMS INSTITUUT BIOTECHNOLOGIE FLANDERS INSTITUTE FOR BIOTECHNOLOGY
Belgium, ZWIJNAARDE - GENT
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 topics.
Guests see up to 5 keywords.
